<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Intra myocardial <z:mp ids='MP_0001914'>hemorrhage</z:mp> lesions (IMH) are underdiagnosed complication of ST elevation <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We sought to determine the incidence, predictors and the prognostic value of IMH in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> using cardiac <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging (CMR) techniques </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We screened for inclusion consecutive patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> treated by percutaneous coronary intervention (PCI) within the first 12 hr of evolution </plain></SENT>
<SENT sid="3" pm="."><plain>IMH lesions were identified on T2-weighted sequences on CMR between days 4 and 8 after PCI </plain></SENT>
<SENT sid="4" pm="."><plain>Adverse cardiac events were defined as a composite of <z:hpo ids='HP_0011420'>death</z:hpo> + severe <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> + <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndrome + <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: N = 114 patients were included and n = 11 patients (10%) presented IMH lesions </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with IMH lesions had a larger <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> extent (25.6 ± 1.8 vs. 13.5 ± 1.0 % LV mass, P &lt; 0.01), microvascular obstructive lesions extent (4.6 ± 1.0 vs. 1.3 ± 0.3% LV mass, P &lt; 0.01) and lower LV ejection fraction (40.7 ± 2.3% vs. 50.7 ± 1.3%, P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>The value of glycemia at admission was an independent predictor of IMH development (Odd ratio 1.8 [1.1-2.8] per mmol l(-1), P = 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>The incidence of adverse cardiac events was higher in the IMH group than in the non-IMH group during the first year following <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> (P = 0.01, log-rank analysis) </plain></SENT>
<SENT sid="9" pm="."><plain>Cox regression analysis identified the presence of IMH lesions as an independent predictor of adverse clinical outcome (Hazard Ratio = 2.8 [1.2-6.8], P = 0.02) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Our study indicates that IMH is a rare but severe finding in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e>, associated with a larger <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and a worse clinical outcome </plain></SENT>
<SENT sid="11" pm="."><plain>Per-PCI glycemia might influence IMH development </plain></SENT>
</text></document>